vistusertib
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for vistusertib, covering 2021-01-06 to 2023-05-03. Get the full timeline:
Most recent: Clinical Trial Update: Navitoclax and Vistusertib in Treating Patients With Relapsed Small Cell Lung Cancer and Other Solid Tumors [Phase 1, Phase 2]